Genotyping is the fastest way to identify antibiotic resistance.
The Power of Genomics
In a collaboration with Merck & Co., OpGen gained access to the Study for Monitoring Antimicrobial Resistance Trends (SMART) surveillance program, a curated library of more than 250,000 bacterial isolates from over 190 hospitals in over 50 countries. Using this access to one of the world’s largest surveillance studies of antimicrobial resistance, a universe of 20,000 known resistance genes was distilled to a comprehensive set with clinical utility and one suitable for a rapid diagnostic platform. Combined with the informatics of the Acuitas Lighthouse, resistance to a broad range of antibiotics can be now determined in hours instead of the days currently required for traditional methods.
The Acuitas AMR Gene Panel is a rapid diagnostic test for the detection of antimicrobial resistance. It is a highly multiplexed PCR test with an easy-to-use workflow and it reports results in less than 3 hours. Results can be uploaded to the Acuitas Lighthouse for the prediction of antibiotic resistance and for real-time surveillance of AMR threats. It is available for research use only and not for use in diagnostic procedures.
Acuitas Whole Genome Sequencing is a service offering available for more comprehensive genotyping of bacterial isolates. We can sequence your isolates and provide bioinformatic analysis or we can provide the analysis on sequences you provide to us in silico. It is available for research use only and not for use in diagnostic procedures.